HOME >> MEDICINE >> NEWS
The Molecular Profiling Institute, Inc. and IBM advance technology

The Molecular Profiling Institute, Inc. (Molecular Profiling) announced today that its alliance with IBM on the Healthcare Life Sciences Collaboration Project is generating tools that allow for improved personalized medicine offerings and better patient care.

As a result of the collaboration, Molecular Profiling anticipates being able to offer to physicians, in conjunction with their ordering of diagnostic tests from Molecular Profiling, a Personalized Medicine Expert System (PerMedEx). PerMedEx is a sophisticated, proprietary system that allows physicians a high throughput reporting structure to better apply genomic advances to the practice of medicine. The system allows for a more tailored treatment strategy and enhanced reporting, follow-up and more holistic management of the patient's condition.

"The goal of the Molecular Profiling Institute is to give physicians the tools they need to provide a greater level of personalized medicine in the treatment of their patients," said Dr. Robert J. Penny, the president and CEO of Molecular Profiling. "Our alliance with IBM should allow Molecular Profiling to offer physicians a tailored medical strategy for their individual patients."

IBM and Molecular Profiling's joint effort to create a CDI solution is aimed at helping battle cancer by combining IBM's hardware/software expertise and MPI's genomics/clinical expertise. At this stage in the development, Molecular Profiling provides clinical data, modeling, and system testing. Molecular Profiling is also designing and building a Clinical Information Management System (CIMS) and genomic analytic software (GAS), along with synonym and taxonomy dictionaries. IBM's focus on this phase of this project is principally on the development of the infrastructure of CDI, including data repositories, knowledge management, workflow management and user interfaces.

"The industry is aware of the benefits of incorporating informatics capabilities int
'"/>

Contact: Dr. Robert Penny
rpenny@molecularprofiling.com
602-358-8901
The Translational Genomics Research Institute
8-Nov-2005


Page: 1 2 3

Related medicine news :

1. Elsevier launches Molecular Oncology
2. Molecular marker may help identify pancreatic cancer, and possibly predict survival time
3. Molecular differences between early and advanced melanomas could provide new drug targets
4. Molecular structure reveals how botulinum toxin attaches to nerve cells
5. Molecular medicine comes to the rescue
6. Molecular switch may turn off immune cells that target HIV
7. Molecular imaging may lead to earlier diagnosis of childhood respiratory virus
8. Molecular Profiling Institute secures $7.5 million in Series B funding
9. Molecular studies in cancer of the colon
10. Molecular ballet unravels, links proteins so cell can direct own movement
11. Molecular testing in patients with rare cancer predicts response to Gleevec

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... , ... May 04, 2016 , ... ... master charity program created to assist the people of their local community. The ... nonprofit organizations and community leaders. Their hope is to bring awareness to important ...
(Date:5/4/2016)... ... May 04, 2016 , ... Momsense, Inc. ... mothers. The company’s patented technology, The Smart Breastfeeding Meter, is designed to monitor ... the technology is now available for purchase at Target.com . , ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... the pharmacy industry, today announced that it was chosen as the Pharmaceutical News ... Industry Awards . The awards acknowledge the hard work and dedication of community ...
(Date:5/4/2016)... Sac, Wisconsin (PRWEB) , ... ... ... collection delivers next-level compression and support for knees, ankles, and elbows. Engineered ... value. , Innovative 3D flat-bed manufacturing (opposed to ineffective circular knitting, common ...
(Date:5/4/2016)... ... 2016 , ... DESCO Medical Service, also known as Diagnostic ... service and sales company located in Pennsylvania. The terms of the deal were ... management services to the medical and academic research industries. The acquisition will help ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Acute Myeloid ... 2016"  report to their offering.  ... ,Global Acute Myeloid Leukemia Market and Competitive ... Acute Myeloid Leukemia pipeline products, Acute Myeloid ...
(Date:5/3/2016)... 4, 2016 Global Insulin ... profiling 09 key companies and supported with 272 ... in-depth study on the current state of the ... the industry including definitions, classifications, applications and industry ... provided for the international market including development history, ...
Breaking Medicine Technology:
Cached News: